title: Studies on the antinephritic effects of plant components (6): antinephritic effects and mechanisms of phellodendrine (OB-5) on crescentic-type anti-GBM nephritis in rats (2).
abstract: Effects of phellodendrine (OB-5) on crescentic-type anti-GBM nephritis in rats and the cell number of the various leukocyte subpopulations in the glomeruli of the nephritic rats were investigated. OB-5 at 25, 50 and 100 mg/kg/day, p.o. prevented the urinary protein excretion by the 19th day after i.v.-injection of anti-GBM serum. In the OB-5-treated rats, plasma cholesterol and creatinine contents were lower than those of the control rats throughout the 40-day experimental period. Histopathological observations demonstrated that OB-5 inhibited the incidence of crescent formation, adhesion and fibrinoid necrosis in the glomeruli by the 41st day. OB-5 did not affect the plasma antibody titer against rabbit gamma globulin. The increases in total leukocytes, macrophages, cytotoxic/suppressor T cells, Ia positive cells, and IL-2 receptor positive cells in the glomeruli in OB-5, 100 mg/kg-treated rats as well as those of the animals treated with azathioprine or cyclosporin A were lower than those of the anti-GBM nephritic control. These results indicate that OB-5 was effective in crescentic-type anti-GBM nephritis and the antinephritic mechanisms of this agent may be due to its ability to inhibit the proliferation or the migration of macrophages and cytotoxic T lymphocytes in the glomeruli.
authors: Department of Pharmacology, Faculty of Pharmacy, Meijo University, Nagoya, Japan.
authors: T
authors: T
authors: Hattori
authors: K
authors: K
authors: Furuta
authors: K
authors: K
authors: Hayashi
authors: T
authors: T
authors: Nagamatsu
authors: M
authors: M
authors: Ito
authors: Y
authors: Y
authors: Suzuki
mesh_terms: D000818:Animals; D000906:Antibodies / Q000276:immunology; D000911:Antibodies, Monoclonal / Q000276:immunology; D001379:Azathioprine / Q000494:pharmacology; D001485:Basement Membrane / Q000276:immunology; D002784:Cholesterol / Q000097:blood; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000494:pharmacology; D005921:Glomerulonephritis / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology; D007150:Immunohistochemistry; D007678:Kidney Glomerulus / Q000276:immunology; D008297:Male; D011507:Proteinuria / Q000652:urine; D011807:Quinolizines / Q000627:therapeutic use*; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: D000906:Antibodies; D000911:Antibodies, Monoclonal; D011807:Quinolizines; C079418:phellodendrine; D016572:Cyclosporine; D002784:Cholesterol; D003404:Creatinine; D001379:Azathioprine